Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-005883
Filing Date
2015-07-30
Accepted
2015-07-30 17:16:23
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20150630.htm 10-Q 739933
2 EX-31.1 mnov-ex311_8.htm EX-31.1 10987
3 EX-31.2 mnov-ex312_9.htm EX-31.2 10913
4 EX-32.1 mnov-ex321_10.htm EX-32.1 7869
5 EX-32.2 mnov-ex322_11.htm EX-32.2 7818
  Complete submission text file 0001564590-15-005883.txt   2712177

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20150630.xml EX-101.INS 450114
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20150630.xsd EX-101.SCH 26340
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20150630_cal.xml EX-101.CAL 25706
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20150630_def.xml EX-101.DEF 56613
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20150630_lab.xml EX-101.LAB 214015
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20150630_pre.xml EX-101.PRE 149003
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 151017140
SIC: 2834 Pharmaceutical Preparations